NCT02579681 - Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012 | Biotech Hunter

Enrollment

221

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 21, 2016

Study Completion Date

December 21, 2016

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

dimethyl fumarate

dimethyl fumarate administered as per the arm description

Trial Locations (18)

Research site, Bari

Research site, Cagliari

Research site, Catania

Research site, Cefalù

Research site, Chieti

Research site, Ferrara

Research site, Fidenza

Research site, Florence

Research site, Gallarate

Research site, Genova

Research site, L’Aquila

Research site, Milan

Research site, Napoli

Research site, Orbassano

Research site, Padua

Research site, Palermo

Research site, Pavia

Research site, Roma